Cytokinetics, Incorporated (CYTK)

Cytokinetics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	6,288	8,186	4,336	3,823	1,471	627
Market Cap Growth	115.65%	88.80%	13.41%	159.95%	134.63%	81.29%
Enterprise Value	6,424	8,327	4,304	3,622	1,146	538
PE Ratio	-	-15.56	-11.15	-17.76	-11.55	-5.15
PS Ratio	1675.86	1087.18	45.84	54.29	26.35	23.33
PB Ratio	-18.23	-21.19	-40.18	15.68	12.97	-57.31
P/FCF Ratio	-17.09	-19.69	-13.95	-19.98	-697.39	-6.70
P/OCF Ratio	-17.13	-19.76	-14.48	-26.83	164.46	-6.90
EV/Sales Ratio	1712.10	1105.90	45.50	51.42	20.52	20.02
EV/EBITDA Ratio	-15.02	-17.13	-11.83	-18.42	-10.46	-4.73
EV/EBIT Ratio	-14.65	-16.72	-11.65	-18.21	-10.29	-4.67
EV/FCF Ratio	-17.41	-20.03	-13.84	-18.92	-543.23	-5.75
Debt / Equity Ratio	-1.91	-1.96	-6.95	1.11	1.23	-12.44
Debt / EBITDA Ratio	-1.54	-1.55	-2.06	-1.37	-1.27	-1.20
Debt / FCF Ratio	-1.79	-1.82	-2.41	-1.41	-65.88	-1.45
Quick Ratio	6.98	6.00	9.25	7.28	15.02	8.85
Current Ratio	7.19	6.12	9.40	7.45	15.20	8.98
Asset Turnover	0.01	0.01	0.10	0.10	0.15	0.12
Interest Coverage	-17.65	-17.59	-19.03	-12.10	-6.97	-17.37
Return on Equity (ROE)	136.50%	151.70%	-1498.90%	-149.20%	-365.80%	1505.60%
Return on Assets (ROA)	-67.30%	-65.10%	-41.80%	-30.60%	-34.00%	-55.70%
Return on Capital (ROIC)	-138.80%	-134.31%	-50.47%	-36.26%	-37.23%	-79.01%
Earnings Yield	-8.44%	-6.43%	-8.97%	-5.63%	-8.65%	-19.41%
FCF Yield	-6.72%	-5.08%	-7.17%	-5.01%	-0.14%	-14.92%
Buyback Yield / Dilution	-7.10%	-7.46%	-16.83%	-19.16%	-12.07%	-5.80%
Total Shareholder Return	-7.10%	-7.46%	-16.83%	-19.16%	-12.07%	-5.80%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).